Cravath, Swaine & Moore LLP Logo
  • Practices
  • People
  • Careers
  • News & Insights
  • Practices
  • People
  • Careers
  • News & Insights
  • Our Story
  • The Cravath System
  • Diversity & Inclusion
  • Pro Bono
  • Alumni Journal
  • 200.Cravath

Cravath’s London Office Moves to 100 Cheapside

Read More

News & Insights

Johnson & Johnson’s Acquisition of Micrus

July 12, 2010

Cravath represented Johnson & Johnson in connection with its entry into a definitive agreement whereby it will acquire Micrus Endovascular, a global developer and manufacturer of minimally invasive devices to address hemorrhagic and ischemic stroke, for approximately $480 million in a cash-for-stock exchange. Under the terms of the agreement, Micrus Endovascular stockholders will receive at closing $23.40 for each outstanding Micrus Endovascular share. The transaction, which has been approved by the boards of directors of both companies, is expected to close in the second half of 2010.

The Cravath team included partner Robert I. Townsend III and associate Sarah R. Kahn on corporate matters; partner Eric W. Hilfers and associate Jarrett R. Hoffman on executive compensation and benefits matters; partner Andrew W. Needham and associates J. Leonard Teti II and Melissa Moszkowski on tax matters;and associate Matthew Morreale on environmental matters.

Related Practices & Industries

  • Corporate
  • Mergers and Acquisitions
  • Environmental
  • Executive Compensation and Benefits
  • Tax
  • Healthcare and Life Sciences

People

Photo
Name
Robert I. Townsend III
Title
Corporate
Title
Partner
Email
rtownsend@cravath.com
Phone
+1-212-474-1964
vCard
Download vCard

    Education

    • J.D., 1990, Harvard Law School
      magna cum laude
    • A.B., 1987, Harvard College
      magna cum laude

    Admitted In

    • New York
    Photo
    Name
    Eric W. Hilfers
    Title
    Executive Compensation and Benefits
    Title
    Partner
    Email
    ehilfers@cravath.com
    Phone
    +1-212-474-1352
    vCard
    Download vCard

      Education

      • J.D., 1998, University of Chicago Law School
        with Honors
      • A.B., 1995, Princeton University

      Admitted In

      • New York
      Photo
      Name
      Matthew Morreale
      Title
      Corporate
      Title
      Partner
      Email
      mmorreale@cravath.com
      Phone
      +1-212-474-1534
      vCard
      Download vCard

        Education

        • J.D., 1997, Columbia Law School
          Harlan Fiske Stone Scholar
        • M.S., 1994, University of Pennsylvania
        • B.A., 1990, University of Pennsylvania
        • B.A.S., 1990, University of Pennsylvania

        Admitted In

        • New York
        Photo
        Name
        J. Leonard Teti II
        Title
        Tax
        Title
        Partner
        Email
        lteti@cravath.com
        Phone
        +1-212-474-1896
        vCard
        Download vCard

          Education

          • J.D., 2005, University of Virginia School of Law
            Order of the Coif
          • A.B., 1999, Princeton University
            with Honors

          Admitted In

          • New York
          Photo
          Name
          Andrew W. Needham
          Title
          Tax
          Title
          Retired Partner
          Email
          aneedham@cravath.com
          Phone
          +1-212-474-9999
          vCard
          Download vCard

            Education

            • M.B.A., 1992, The Wharton School of the University of Pennsylvania
            • LL.M., 1990, Georgetown University Law Center
            • J.D., 1986, Georgetown University Law Center
            • B.A., 1982, University of Arizona College of Law

            Related News & Insights

            Deals & Cases

            March 12, 2025

            Johnson & Johnson’s $5 Billion Registered Notes Offering and Concurrent €4 Billion Notes Offering

            Cravath represented the underwriters in connection with the $5 billion registered notes offering of Johnson & Johnson, the world’s largest, most diversified healthcare products company. Cravath also represented the underwriters in connection with Johnson & Johnson’s concurrent €4 billion notes offering. Proceeds of both offerings will be used to finance the acquisition of Intra‑Cellular Therapies, Inc. by Johnson & Johnson. The transactions closed on February 20, 2025, and February 26, 2025, respectively.

            Cravath Bicentennial

            Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

            Explore

            Cravath, Swaine & Moore LLP Logo
            • CONTACT US
            • OUR STORY
            • ALUMNI PORTAL
            • DISCLAIMERS & NOTICES

            Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.